CEFPROZIL ANHYDROUS, (E)-

SynDRA canonical compound SYN0001090 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bronchitis \| otitis \| pharyngitis \| respiratory tract infections \| sinusitis \| skin infections \| tonsillitis
Disease area	infectious disease \| otolaryngology \| pulmonary

All known targets

cefprozil
cefprozile
cephprozyl
cefprozil hydrate
Cefprozil
Arzimol
Brisoral
Cefprozilo
Cefprozilum
Cefzil
Cronocef
Procef
Serozil
Cefprozil anhydrous
BMY 28100
Cefprozil (INN)
Cefprozil (TN)
Cefprozilo [INN-Spanish]
Cefprozilum [INN-Latin]
Cefzil (TN)
Procef (TN)
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Cefprozil (E)-isomer
S1SDI2FJIY
Cefprozil anhydrous, e-isomer
trans-Cefprozil
Cefprozil hydrate (Cefzil)
CEFPROZIL (E)-ISOMER (50 MG)G0D341872UG/MG(AI)
E-Cefprozil
Cefprozil Impurity 8
Cefprozil [USAN:INN]
UNII-1M698F4H4E
(E)-cefprozil
UNII-S1SDI2FJIY
Cefprozil, mix of Z (92%), and E (7%) isomers
CEFPROZIL [MART.]
BIDD:GT0833
SCHEMBL537035